K883279 is an FDA 510(k) clearance for the PHASE II FSH KIT. Classified as Radioimmunoassay, Follicle-stimulating Hormone (product code CGJ), Class I - General Controls.
Submitted by Vitek Systems, Inc. (Rockland, US). The FDA issued a Cleared decision on September 9, 1988 after a review of 37 days - a notably fast clearance cycle.
This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1300 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Vitek Systems, Inc. devices